Brainsway Ltd (BRSYF) 3.2200 $BRSYF
Brainsway Opens Mexico Market Through an Exclusive Distribution Agreement With moksha8
GlobeNewswire - Tue Dec 08, 11:04AM CST
Brainsway LTD (TASE:BRIN), a leader in non-invasive brain stimulation, is pleased to announce a new partnership agreement with moksha8, a leader in the commercialization of CNS medicines in Latin America, for the exclusive distribution of Deep TMS (Transcranial Magnetic Stimulation) in Mexico. moksha8 intends to register and start commercialization of several Deep TMS systems in 2016 and has already committed to launch 10 systems in the following 12 months.
Brainsway Enhances Its Clinical Leadership With Appointment of Dr. Aron Tendler as Chief Medical Officer
GlobeNewswire - Mon Oct 19, 8:00AM CDT
Brainsway Ltd. (TASE:BRIN), a leading company in the development of revolutionary brain disorder treatments, today announced that Dr. Aron Tendler, M.D. will assume the role of Chief Medical Officer (CMO) for the company. Dr. Tendler brings years of experience in the treatment of mental disorders as a psychiatrist, and has been using Brainsway Deep TMS for treating depression over the past six years. He has participated in numerous Deep TMS clinical trials, including studies assessing the efficacy of the technology for treatment of depression, bipolar disorder, smoking cessation, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD). In this role, Dr. Tendler will establish and drive the clinical vision of the company, providing executive medical leadership, motivation and guidance to Brainsway's providers. The role will also include the execution and implementation of leadership strategies, including collaborative clinical programs with strategic business partners.
Brainsway Appoints Avi Pozan as VP Global Sales
GlobeNewswire - Mon Aug 17, 2:00PM CDT
Brainsway Ltd (TASE:BRIN) announced this week that it has appointed Avi Pozan to the position of VP Global Sales, effective August 16th, 2015.
Global Medical Devices: Business Daily - Business News for Leading Global Medical Devices/Technology/Supplies Companies
M2 - Thu May 21, 10:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m3gfjv/global_medical) has announced the addition of the "Global Medical Devices: Business Daily" report to their offering. The author offers Global Medical Devices: Business Daily, which delivers all business news for leading global medical devices/technology/supplies companies daily, that helps companies/investors to follow-up on new business opportunities in the global medical devices/technology/supplies industry. The global medical device industry is growing rapidly and is likely to continue going from strength to strength. The industry as a whole is growing largely because of an aging global population and climbing societal risk factors. In particular, diet-related chronic diseases, such as cardiovascular disease and diabetes, continue to create demand for medical healthcare services. Equally, the need for medical devices continues to climb, with life expectancy jumping nearly 20 years over the past 50 years. The author which has been providing company and financial information globally since two decades, brings-out every day at 9 am New York time Global Medical Devices: Business Daily report for global medical devices/technology/supplies companies. The objective of this daily business news digest is to analyze and summarize the key news for leading global medical devices/technology/supplies companies daily. The Daily helps the investors globally to assess the investment trends and opportunities in the global medical devices/technology/supplies business. Highlights: - Covers all the important business transactions of the day - Provides list of companies covered daily - Company news presented by region, country, and company name - Company news also presented by news category - Ticker mentioned for all listed companies included in news Companies Mentioned Each daily covers different medical devices/technology/supplies companies worldwide. The sample list of company names included in the latest three dailies is mentioned below: - 3M Company (United States) - AB Sciex (United States) - Apnea Sciences Corporation (United States) - Apollo Endosurgery Inc. (United States) - Arc Medical Design Ltd. (United Kingdom) - Atossa Genetics Inc. (United States) - Avinger Inc. (United States) - Biolase Incorporation (United States) - Brainsway Ltd. (Israel) - Cardiovascular Systems Inc. (United States) - CoNextions Medical (United States) - Cryonic Medical SA (France) - CU Medical Systems Inc. (South Korea) - Cynosure Inc. (United States) - Dentsply International Inc. (Israel) - Direct Flow Medical Inc. (United States) - Edwards Lifesciences Corporation (United States) - EnteroMedics Inc. (United States) - Exact Imaging (Canada) - Exosome Diagnostics Inc. (United States) For more information visit http://www.researchandmarkets.com/research/m3...al_medical
AVGR: 10.90 (-0.47), ATOS: 0.29 (-0.01), MMM: 168.94 (-0.99), CYNO: 48.40 (-0.73), CSII: 17.15 (-0.87), BIOL: 1.16 (-0.03), EW: 98.54 (-0.77)
Dr. Guy Ezekiel Named Brainsway's New President & CEO
PR Newswire - Mon May 18, 4:54AM CDT
Brainsway Ltd., (TASE: BRIN), the creator of Deep TMS(TM) systems for the treatment of brain disorders, today annouced that it has appointed Guy Ezekial, M.D. (45) to serve as its new President and CEO beginning on June 15, 2015.
Leading 100 Global Medical Technology Companies Currently Not Active in India: 2015 An Industry Report
M2 - Mon Mar 09, 5:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2pvzl5/global_medical) has announced the addition of the "Global Medical Technology Not Active in India 100: An Industry Report" report to their offering. The global medical technology industry's market size stands at approximately 350 billion U.S. dollars and is forecasted to grow at 4.4 percent per year to reach $440 billion by 2018. The industry will continue to benefit from emerging market investments that are lifting standards of care, while cost conscious developed markets will continue to invest in more efficient machines, systems and procedures, which offer less hospital time and better patient outcomes. In India, the medical technology industry, the size of which is USD 6.3 billion at present, has the potential to expand to USD 50 billion by 2025 due to its large population, growing middle class, and improving healthcare infrastructure. Further, India, where its forte in software technology is widely-known has initiated steps to involve constructively in the medical technology sector through home-grown innovation as well as through foreign-alliances. With quality R&D skills available locally, India is expected to play a more influential role here. Thus, the global medical technology companies which have not yet set a foot in the Indian medical technology industry need to plan ahead to enter the Indian market. Report Highlights: - Leading global 100 medical technology companies with no presence in India - Integration of company news and industry news, as well as rankings - Important M&A and alliances among global medical technology companies not active in India - International presence of global medical technology companies not active in India - R&D activities by global medical technology companies not active in India Companies Mentioned: Partial List of Companies Featured - A&T Corporation (Japan) - Advanced Technology Company (Kuwait) - Align Technology, Inc. (United States) - Asiamedic Limited (Singapore) - Azure Healthcare Ltd(Australia) - Bio View Ltd. (Israel) - Bioquell plc(United Kingdom) - Brain Resource Ltd (Australia) - Brainsway Ltd.(Israel) - Cellavision AB (Sweden) - China Resources Wandong Medical Equipment Company Limited (China) - Cogstate Ltd.(Australia) - Cryolife, Inc. (United States) - Cyclopharm Limited(Australia) - Diagnosticos da America S.A.(Brazil) - Digirad Corporation (United States) - DongGuan Eontec Co, Ltd(China) - Draegerwerk AG & Co KGaA (Germany) - Dvx Inc (Japan) - Electrical Geodesics, Inc.(United States) For more information visit http://www.researchandmarkets.com/research/2p...al_medical
ALGN: 79.17 (-0.18)
Brainsway Receives IDE Approval From FDA for Launching Pivotal PTSD Multi-Center Trial
GlobeNewswire - Mon Dec 15, 7:01AM CST
Brainsway Ltd. (TASE:BRIN) announced that it received an IDE (Investigational Device Exemptions) approval from the FDA for launching a Multi-Center trial which will examine the effectiveness of Brainsway's Deep TMS (Deep Transcranial Magnetic Stimulation) for treating PTSD (Post Traumatic Stress Disorder) patients. The approval was given for 166 patients and 15 medical centers.
Brainsway Receives CE Approvals for Treating Multiple Sclerosis (MS), Stroke and Obsessive Compulsive Disorder (OCD)
GlobeNewswire - Thu Dec 04, 7:06AM CST
Brainsway Ltd. (TASE:BRIN) announced that it received a CE Marketing Approval, enabling it to immediately market and sell Brainsway Deep TMS (Deep Transcranial Magnetic Stimulation) in Europe, for treatment of Multiple Sclerosis (MS), Stroke and Obsessive Compulsive Disorder (OCD).
Brainsway Wins 2014 FLC Mid-Atlantic Regional Award for Excellence in Technology Transfer
GlobeNewswire - Mon Oct 13, 8:00AM CDT
Brainsway Ltd. (TASE:BRIN) announced that its Deep TMS treatment has won the 2014 Federal Laboratory Consortium for Technology Transfer (FLC) Mid-Atlantic Regional Award for Excellence in Technology Transfer.
Brainsway Opens Mexico Market Through an Exclusive Distribution Agreement With moksha8
GlobeNewswire - Tue Dec 08, 11:04AM CST
Brainsway LTD (TASE:BRIN), a leader in non-invasive brain stimulation, is pleased to announce a new partnership agreement with moksha8, a leader in the commercialization of CNS medicines in Latin America, for the exclusive distribution of Deep TMS (Transcranial Magnetic Stimulation) in Mexico. moksha8 intends to register and start commercialization of several Deep TMS systems in 2016 and has already committed to launch 10 systems in the following 12 months.
Brainsway Enhances Its Clinical Leadership With Appointment of Dr. Aron Tendler as Chief Medical Officer
GlobeNewswire - Mon Oct 19, 8:00AM CDT
Brainsway Ltd. (TASE:BRIN), a leading company in the development of revolutionary brain disorder treatments, today announced that Dr. Aron Tendler, M.D. will assume the role of Chief Medical Officer (CMO) for the company. Dr. Tendler brings years of experience in the treatment of mental disorders as a psychiatrist, and has been using Brainsway Deep TMS for treating depression over the past six years. He has participated in numerous Deep TMS clinical trials, including studies assessing the efficacy of the technology for treatment of depression, bipolar disorder, smoking cessation, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD). In this role, Dr. Tendler will establish and drive the clinical vision of the company, providing executive medical leadership, motivation and guidance to Brainsway's providers. The role will also include the execution and implementation of leadership strategies, including collaborative clinical programs with strategic business partners.
Brainsway Appoints Avi Pozan as VP Global Sales
GlobeNewswire - Mon Aug 17, 2:00PM CDT
Brainsway Ltd (TASE:BRIN) announced this week that it has appointed Avi Pozan to the position of VP Global Sales, effective August 16th, 2015.
Global Medical Devices: Business Daily - Business News for Leading Global Medical Devices/Technology/Supplies Companies
M2 - Thu May 21, 10:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m3gfjv/global_medical) has announced the addition of the "Global Medical Devices: Business Daily" report to their offering. The author offers Global Medical Devices: Business Daily, which delivers all business news for leading global medical devices/technology/supplies companies daily, that helps companies/investors to follow-up on new business opportunities in the global medical devices/technology/supplies industry. The global medical device industry is growing rapidly and is likely to continue going from strength to strength. The industry as a whole is growing largely because of an aging global population and climbing societal risk factors. In particular, diet-related chronic diseases, such as cardiovascular disease and diabetes, continue to create demand for medical healthcare services. Equally, the need for medical devices continues to climb, with life expectancy jumping nearly 20 years over the past 50 years. The author which has been providing company and financial information globally since two decades, brings-out every day at 9 am New York time Global Medical Devices: Business Daily report for global medical devices/technology/supplies companies. The objective of this daily business news digest is to analyze and summarize the key news for leading global medical devices/technology/supplies companies daily. The Daily helps the investors globally to assess the investment trends and opportunities in the global medical devices/technology/supplies business. Highlights: - Covers all the important business transactions of the day - Provides list of companies covered daily - Company news presented by region, country, and company name - Company news also presented by news category - Ticker mentioned for all listed companies included in news Companies Mentioned Each daily covers different medical devices/technology/supplies companies worldwide. The sample list of company names included in the latest three dailies is mentioned below: - 3M Company (United States) - AB Sciex (United States) - Apnea Sciences Corporation (United States) - Apollo Endosurgery Inc. (United States) - Arc Medical Design Ltd. (United Kingdom) - Atossa Genetics Inc. (United States) - Avinger Inc. (United States) - Biolase Incorporation (United States) - Brainsway Ltd. (Israel) - Cardiovascular Systems Inc. (United States) - CoNextions Medical (United States) - Cryonic Medical SA (France) - CU Medical Systems Inc. (South Korea) - Cynosure Inc. (United States) - Dentsply International Inc. (Israel) - Direct Flow Medical Inc. (United States) - Edwards Lifesciences Corporation (United States) - EnteroMedics Inc. (United States) - Exact Imaging (Canada) - Exosome Diagnostics Inc. (United States) For more information visit http://www.researchandmarkets.com/research/m3...al_medical
AVGR: 10.90 (-0.47), ATOS: 0.29 (-0.01), MMM: 168.94 (-0.99), CYNO: 48.40 (-0.73), CSII: 17.15 (-0.87), BIOL: 1.16 (-0.03), EW: 98.54 (-0.77)
Dr. Guy Ezekiel Named Brainsway's New President & CEO
PR Newswire - Mon May 18, 4:54AM CDT
Brainsway Ltd., (TASE: BRIN), the creator of Deep TMS(TM) systems for the treatment of brain disorders, today annouced that it has appointed Guy Ezekial, M.D. (45) to serve as its new President and CEO beginning on June 15, 2015.
Leading 100 Global Medical Technology Companies Currently Not Active in India: 2015 An Industry Report
M2 - Mon Mar 09, 5:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2pvzl5/global_medical) has announced the addition of the "Global Medical Technology Not Active in India 100: An Industry Report" report to their offering. The global medical technology industry's market size stands at approximately 350 billion U.S. dollars and is forecasted to grow at 4.4 percent per year to reach $440 billion by 2018. The industry will continue to benefit from emerging market investments that are lifting standards of care, while cost conscious developed markets will continue to invest in more efficient machines, systems and procedures, which offer less hospital time and better patient outcomes. In India, the medical technology industry, the size of which is USD 6.3 billion at present, has the potential to expand to USD 50 billion by 2025 due to its large population, growing middle class, and improving healthcare infrastructure. Further, India, where its forte in software technology is widely-known has initiated steps to involve constructively in the medical technology sector through home-grown innovation as well as through foreign-alliances. With quality R&D skills available locally, India is expected to play a more influential role here. Thus, the global medical technology companies which have not yet set a foot in the Indian medical technology industry need to plan ahead to enter the Indian market. Report Highlights: - Leading global 100 medical technology companies with no presence in India - Integration of company news and industry news, as well as rankings - Important M&A and alliances among global medical technology companies not active in India - International presence of global medical technology companies not active in India - R&D activities by global medical technology companies not active in India Companies Mentioned: Partial List of Companies Featured - A&T Corporation (Japan) - Advanced Technology Company (Kuwait) - Align Technology, Inc. (United States) - Asiamedic Limited (Singapore) - Azure Healthcare Ltd(Australia) - Bio View Ltd. (Israel) - Bioquell plc(United Kingdom) - Brain Resource Ltd (Australia) - Brainsway Ltd.(Israel) - Cellavision AB (Sweden) - China Resources Wandong Medical Equipment Company Limited (China) - Cogstate Ltd.(Australia) - Cryolife, Inc. (United States) - Cyclopharm Limited(Australia) - Diagnosticos da America S.A.(Brazil) - Digirad Corporation (United States) - DongGuan Eontec Co, Ltd(China) - Draegerwerk AG & Co KGaA (Germany) - Dvx Inc (Japan) - Electrical Geodesics, Inc.(United States) For more information visit http://www.researchandmarkets.com/research/2p...al_medical
ALGN: 79.17 (-0.18)
Brainsway Receives IDE Approval From FDA for Launching Pivotal PTSD Multi-Center Trial
GlobeNewswire - Mon Dec 15, 7:01AM CST
Brainsway Ltd. (TASE:BRIN) announced that it received an IDE (Investigational Device Exemptions) approval from the FDA for launching a Multi-Center trial which will examine the effectiveness of Brainsway's Deep TMS (Deep Transcranial Magnetic Stimulation) for treating PTSD (Post Traumatic Stress Disorder) patients. The approval was given for 166 patients and 15 medical centers.
Brainsway Receives CE Approvals for Treating Multiple Sclerosis (MS), Stroke and Obsessive Compulsive Disorder (OCD)
GlobeNewswire - Thu Dec 04, 7:06AM CST
Brainsway Ltd. (TASE:BRIN) announced that it received a CE Marketing Approval, enabling it to immediately market and sell Brainsway Deep TMS (Deep Transcranial Magnetic Stimulation) in Europe, for treatment of Multiple Sclerosis (MS), Stroke and Obsessive Compulsive Disorder (OCD).
Brainsway Wins 2014 FLC Mid-Atlantic Regional Award for Excellence in Technology Transfer
GlobeNewswire - Mon Oct 13, 8:00AM CDT
Brainsway Ltd. (TASE:BRIN) announced that its Deep TMS treatment has won the 2014 Federal Laboratory Consortium for Technology Transfer (FLC) Mid-Atlantic Regional Award for Excellence in Technology Transfer.
